CA2340457A1 - Recepteur couple a la proteine g, dit recepteur 14400 - Google Patents

Recepteur couple a la proteine g, dit recepteur 14400 Download PDF

Info

Publication number
CA2340457A1
CA2340457A1 CA002340457A CA2340457A CA2340457A1 CA 2340457 A1 CA2340457 A1 CA 2340457A1 CA 002340457 A CA002340457 A CA 002340457A CA 2340457 A CA2340457 A CA 2340457A CA 2340457 A1 CA2340457 A1 CA 2340457A1
Authority
CA
Canada
Prior art keywords
amino acid
receptor
nucleic acid
polypeptide
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002340457A
Other languages
English (en)
Inventor
Maria Alexandra Glucksmann
Nadine S. Weich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2340457A1 publication Critical patent/CA2340457A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • A61P33/12Schistosomicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne un récepteur récemment identifié qui appartient à la superfamille des récepteurs couplés à la protéine G. Elle concerne également les polynucléotides codant pour ce récepteur. De plus, l'invention porte sur des méthodes d'utilisation des polypeptides et des polynucléotides de ce récepteur en tant que cible pour le diagnostic et le traitement de troubles induits par ce récepteur. Elle concerne également des procédés de criblage de médicaments qui font intervenir les polypeptides et les polynucléotides de ce récepteur dans le but d'identifier des agonistes et des antagonistes à des fins de diagnostic et de traitement. Elle concerne en outre les agonistes et les antagonistes basés sur les polypeptides et les polynucléotides de ce récepteur. Enfin, l'invention s'intéresse à des procédés permettant d'obtenir les polypeptides et les polynucléotides de ce récepteur.
CA002340457A 1998-08-20 1999-08-20 Recepteur couple a la proteine g, dit recepteur 14400 Abandoned CA2340457A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13706398A 1998-08-20 1998-08-20
US09/137,063 1998-08-20
US37810099A 1999-08-20 1999-08-20
US09/378,100 1999-08-20
PCT/US1999/019112 WO2000011170A1 (fr) 1998-08-20 1999-08-20 Recepteur couple a la proteine g, dit recepteur 14400

Publications (1)

Publication Number Publication Date
CA2340457A1 true CA2340457A1 (fr) 2000-03-02

Family

ID=26834887

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002340457A Abandoned CA2340457A1 (fr) 1998-08-20 1999-08-20 Recepteur couple a la proteine g, dit recepteur 14400

Country Status (5)

Country Link
EP (1) EP1104465A1 (fr)
JP (1) JP2003532369A (fr)
AU (1) AU5578699A (fr)
CA (1) CA2340457A1 (fr)
WO (1) WO2000011170A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
ATE366815T1 (de) * 1998-11-20 2007-08-15 Arena Pharm Inc Menschliche, an ein g-protein gekoppelter rezeptor rup3 ohne bekannten ligand
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
WO2002000700A2 (fr) * 2000-06-26 2002-01-03 Bayer Aktiengesellschaft Regulation du recepteur couple a la proteine g semblable a la p2y8 humaine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997019170A1 (fr) * 1995-11-21 1997-05-29 Euroscreen S.A. Recepteur et molecule d'acide nucleique codant ledit recepteur

Also Published As

Publication number Publication date
WO2000011170A1 (fr) 2000-03-02
EP1104465A1 (fr) 2001-06-06
JP2003532369A (ja) 2003-11-05
AU5578699A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
US20030129644A1 (en) 14274 receptor, a novel G-protein coupled receptor related to the EDG receptor family
US20060099687A1 (en) 14926 Receptor, a novel G-protein coupled receptor
US20030040052A1 (en) Novel G-protein coupled receptors
WO2000023588A9 (fr) Recepteurs couples a la proteine g
US20030166042A1 (en) Novel seven-transmembrane proteins/G-protein coupled receptors
EP1127126B1 (fr) Recepteurs a couplage de proteine g, homologues de gpcr 2 induits par ebv (ebi-2), et procedes permettant de rechercher certains de leurs ligands
EP1246916A2 (fr) 26904, 38911 et 39404, nouvelles proteines a sept segments transmembranaires/recepteurs couples aux proteines g
CA2340457A1 (fr) Recepteur couple a la proteine g, dit recepteur 14400
US20010044130A1 (en) 39406 protein, a novel seven transmembrane protein
US20030017539A1 (en) Novel nucleic acid sequences encoding G-protein coupled receptors
US20030162172A1 (en) 2871 receptor, a novel G-protein coupled receptor
EP1248842A1 (fr) Recepteur 2871, recepteur couple a la proteine g et ses procedes d'utilisation
US20020042058A1 (en) 18057 protein, a novel seven transmembrane protein
US20080051322A1 (en) 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors
WO2000032774A1 (fr) Recepteur 12216: recepteur couple a la proteine g
US20030108928A1 (en) MID 241 receptor, a novel G-protein coupled receptor
WO2001059116A2 (fr) Proteine 19459: une nouvelle proteine a sept segments transmembranaires
AU1211100A (en) G-protein coupled receptors

Legal Events

Date Code Title Description
FZDE Dead